Clinical Trials Browser

INDUSTRY × Nausea × Clear all

NCT06904235 2026-03-31

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Phase 2 Recruiting

Nausea, Vomiting

NCT07169851 2026-03-20

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Phase 2 Recruiting

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT00343460 2026-03-02

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

Phase 3 Completed

1,428 enrolled 21 charts

Nausea, Vomiting

NCT00285051 2020-12-23

Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy

Phase 2 Terminated

Nausea, Neoplasms, Vomiting

NCT01636947 2018-09-25

KMEC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

NCT00601172 2018-01-17

A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

Phase 3 Completed

710 enrolled 29 charts

Gastrointestinal

Nausea, Vomiting, Colorectal Neoplasms

NCT00334646 2017-11-17

Cyclophosphamide Drug Interaction Study In Cancer Patients

Phase 1 Terminated

Nausea, Vomiting

NCT00431236 2017-08-22

A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Phase 3 Completed

Nausea, Vomiting

NCT00440128 2017-08-04

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

Phase 1 Completed

Nausea, Vomiting

NCT00684463 2017-05-16

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

Phase 4 Completed

Nausea, Neoplasms, Vomiting

NCT00687011 2017-05-15

Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

Phase 4 Completed

Nausea, Neoplasms, Vomiting

NCT00092183 2017-05-05

An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)

Phase 4 Completed

Breast Neoplasms, Nausea, Vomiting

NCT00092196 2017-05-05

Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)

Phase 3 Completed

Breast Neoplasms, Nausea, Vomiting

NCT01887314 2016-01-27

Efficacy Study of Ginger (Zingiber Officinale) Extract "Ginpax" to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy

Phase NA Completed

Nausea, Neoplasms, Vomiting

NCT02563951 2016-01-08

Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers

Phase 1 Completed

Nausea, Neoplasms, Vomiting

NCT00891761 2015-04-17

A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Phase 3 Withdrawn

Lung Neoplasms, Nausea, Neoplasms, Vomiting

NCT00212602 2012-06-14

ONO-7436 Phase II Study in Japan

Phase 2 Completed

Nausea, Neoplasms, Vomiting

NCT00169572 2010-05-10

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

Phase 2 Completed

Nausea, Vomiting